Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin
November 28, 3:44 PM
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.

ALLG

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights
November 28, 1:30 PM
Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 62.0% to $1.62 during Tuesday’s regular session. The market value…

AUTL

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

FDA Investigating Serious Risk Of T-cell Malignancy Following BCMA-Directed Or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T Cell Immunotherapies

By Benzinga Newsdesk
November 28, 1:25 PM
https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-investigating-serious-risk-t-cell-malignancy-following-bcma-directed-or-cd19-directed-autologous Summary of the IssueThe Food and Drug

CABA

Read More
2 minute read
  • Analyst Ratings

Cantor Fitzgerald Maintains Overweight Rating for Cabaletta Bio: Here’s What You Need To Know

By Benzinga Insights
November 15, 1:00 PM
Cantor Fitzgerald has decided to maintain its Overweight rating of Cabaletta Bio (NASDAQ:CABA) and raise its price target…

CABA

Read More
2 minute read
  • Analyst Ratings

Where Cabaletta Bio Stands With Analysts

By Benzinga Insights
November 10, 11:00 AM
Analysts have provided the following ratings for Cabaletta Bio (NASDAQ:CABA) within the last quarter: Bullish Somewhat Bullish Indifferent…

CABA

Read More
14 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For October 24, 2023

By Benzinga Insights
October 24, 11:00 AM
Upgrades For Martin Marietta Materials Inc (NYSE:MLM), Seaport Global upgraded the previous rating of Neutral to Buy. For…

ABNB

Read More
2 minute read
  • Analyst Ratings

7 Analysts Have This to Say About Cabaletta Bio

By Benzinga Insights
October 24, 8:00 AM
Cabaletta Bio (NASDAQ:CABA) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

CABA

Read More
7 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For October 19, 2023

By Benzinga Insights
October 19, 11:06 AM
Upgrades According to CL King, the prior rating for Stepan Co (NYSE:SCL) was changed from Neutral to Buy.…

BBY

Read More
2 minute read
  • Analyst Ratings

The Latest Analyst Ratings for Cabaletta Bio

By Benzinga Insights
October 4, 11:00 AM
Analysts have provided the following ratings for Cabaletta Bio (NASDAQ:CABA) within the last quarter: Bullish Somewhat Bullish Indifferent…

CABA

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin
September 18, 1:25 PM
Gainers

AENZ

Posts pagination

Previous 1 2 3 … 6 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service